What's Happening?
Promega Corporation has received validation from the Science Based Targets initiative (SBTi) for its near-term emissions reduction targets. The SBTi is a corporate climate action organization that provides standards and guidance for setting greenhouse
gas emissions reduction targets. Promega's approved targets include a 47% reduction in absolute Scope 1 and 2 emissions by 2030, based on a 2023 baseline. Additionally, the company aims to reduce Scope 3 emissions by 42% by 2030, focusing on capital goods and business travel. Promega also plans to ensure that 67% of its suppliers by spend have committed to SBTi or have published SBTi-aligned reduction targets by 2030. This initiative reflects Promega's commitment to aligning its operations with climate science and enhancing sustainability across its value chain.
Why It's Important?
The validation of Promega's emissions reduction targets by SBTi underscores the growing importance of corporate accountability in climate action. By setting science-based targets, Promega not only aligns with global efforts to mitigate climate change but also enhances its credibility and attractiveness to investors and stakeholders. This move is significant for the biotechnology and pharmaceutical industries, where sustainability is increasingly becoming a key factor in procurement and investment decisions. Promega's commitment to reducing emissions and engaging suppliers in sustainability efforts could set a precedent for other companies in the sector, potentially influencing industry standards and practices.
What's Next?
Promega's next steps involve implementing strategies to achieve its emissions reduction targets by 2030. This includes continuing to engage with suppliers to encourage their commitment to science-based targets and focusing on absolute reductions in emissions from capital goods and business travel. The company has already achieved 100% renewable electricity across its global operations, which is a critical step towards meeting its Scope 1 and 2 reduction targets. As Promega progresses, it will likely monitor and report on its sustainability efforts, providing transparency and accountability to stakeholders.
